Phase I/II clinical and pharmacokinetic study of ecubectedin in combination with irinotecan in patients with selected advanced solid tumors

被引：0
|
作者：
Torralvo, A. Gil [1 ]
Vieito, M. [2 ]
Martinez Perez, J. [1 ]
Pretelli, G. [2 ]
Martinez, V. [3 ]
Boggio, G. F. [4 ]
Fernandez, C. M. [4 ]
Hernandez, A. [4 ]
Cristoveanu, E. [4 ]
Belgrano, A. [4 ]
Kahatt, C. [4 ]
Fudio, S. [4 ]
Nieto, A. [4 ]
Redondo, A. [3 ]
机构：
[1] Hosp Univ Virgen Rocio, Oncol, Seville, Spain
[2] VHIO Vall dHebron Inst Oncol, Oncol, Barcelona, Spain
[3] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
[4] PharmaMar SA, Clinical, Colmenar Viejo, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.708
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
641P
引用
收藏
页码：S508 / S508
页数：1
相关论文
共 50 条
  • [21] A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors
    Garland, Linda L.
    Hidalgo, Manuel
    Mendelson, David S.
    Ryan, David P.
    Arun, Banu K.
    Lovalvo, Jennifer L.
    Eiseman, Irene A.
    Olson, Stephen C.
    Lenehan, Peter F.
    Eder, Joseph P.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4274 - 4282
  • [22] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
  • [23] A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies
    Rowinsky, Eric K.
    Beeram, Muralidhar
    Hammond, Lisa A.
    Schwartz, Garry
    De Bono, Johann
    Forouzesh, Baharam
    Chu, Quincy
    Latz, Jane E.
    Hong, Shengyan
    John, William
    Nguyen, Binh
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 532 - 539
  • [24] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
  • [25] Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors
    Misset, JL
    Gamelin, E
    Campone, M
    Delaloge, S
    Latz, JE
    Bozec, L
    Fumoleau, P
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1123 - 1129
  • [26] Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
    Simonelli, Matteo
    Zucali, Paolo A.
    Lorenzi, Elena
    Rubino, Luca
    De Vincenzo, Fabio
    De Sanctis, Rita
    Perrino, Matteo
    Mancini, Luca
    Di Tommaso, Luca
    Rimassa, Lorenza
    Masci, Giovanna
    Zuradelli, Monica
    Suter, Matteo B.
    Bertossi, Monica
    Fattuzzo, Giuseppe
    Giordano, Laura
    Roncalli, Massimo G.
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (05) : 989 - 998
  • [27] Phase I and pharmacokinetic (PK) study of IHL-305 (pegylated liposomal irinotecan) in patients with advanced solid tumors
    Jones, S. F.
    Zamboni, W. C.
    Burris, H. A., III
    Chan, E.
    Infante, J. R.
    Keedy, V.
    Bendell, J. C.
    Lee, W.
    Ikeda, S.
    Rothenberg, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Paz-Ares, Luis
    Forster, Martin
    Boni, Valentina
    Szyldergemajn, Sergio
    Corral, Jesus
    Turnbull, Samantha
    Cubillo, Antonio
    Fernandez Teruel, Carlos
    Lopez Calderero, Iker
    Siguero, Mariano
    Bohan, Patrick
    Calvo, Emiliano
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 198 - 206
  • [29] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Luis Paz-Ares
    Martin Forster
    Valentina Boni
    Sergio Szyldergemajn
    Jesús Corral
    Samantha Turnbull
    Antonio Cubillo
    Carlos Fernandez Teruel
    Iker López Calderero
    Mariano Siguero
    Patrick Bohan
    Emiliano Calvo
    Investigational New Drugs, 2017, 35 : 198 - 206
  • [30] Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors
    Lee, Keun-Wook
    Lee, Dae Ho
    Kang, Jin Hyoung
    Park, Joon Oh
    Kim, Se Hyun
    Hong, Yong Sang
    Kim, Seung Tae
    Oh, Do-Youn
    Bang, Yung-Jue
    ONCOLOGIST, 2018, 23 (02): : 155 - +
12345